FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3933311000001101: Avloclor 250mg tablets (AstraZeneca) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
26520901000001111 Avloclor 250mg tablets (AstraZeneca) 14 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
73317601000001112 Avloclor 250mg tablets (Alliance Pharmaceuticals Ltd) 14 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Avloclor 250mg tablets (AstraZeneca) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Is a Chloroquine phosphate 250mg tablets 14 tablet true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Is pack of Avloclor 250mg tablets (AstraZeneca) false Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Has active ingredient Chloroquine phosphate false Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Legal category Pharmacy medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Has AMP Avloclor 250mg tablets (AstraZeneca) true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Has specific active ingredient Chloroquine phosphate true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Avloclor 250mg tablets (AstraZeneca) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start